miRNAs as biomarkers of musculoskeletal pain in long-distance runners: the MiMuS study protocol

Epigenomics. 2023 Mar;15(6):341-349. doi: 10.2217/epi-2023-0088. Epub 2023 May 30.

Abstract

miRNAs are involved in the generation and progression of musculoskeletal pain, a condition that causes significant clinical, economic and social burden. In runners, the presence of musculoskeletal pain related to an inflammatory state or ongoing underlying tissue damage may result in poor training ability and performance. This study aims to evaluate the association between circulating and salivary miRNAs and pain in runners with and without musculoskeletal pain and to observe whether dysregulated miRNAs can distinguish between responders and nonresponders to a kinesiological intervention. The possible correlation between these miRNAs and inflammatory molecules, stress parameters and individual or behavioral characteristics will be evaluated. Finally, in silico analysis will be used to characterize miRNAs function. Ethics approval was obtained.

Keywords: biomarker; inflammation; microRNA; musculoskeletal pain; runners.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Humans
  • Longitudinal Studies
  • MicroRNAs* / genetics
  • Musculoskeletal Pain* / genetics
  • Running*

Substances

  • MicroRNAs
  • Biomarkers